Biology subjects

Haas, D.

Publications and source records attributed to Haas, D..

6 recordsLinked to original sources

bioRxiv2025

Sympathetic signaling directs macrophage efferocytosis in thermogenic adipose tissue

Brown adipose tissue (BAT) undergoes significant remodeling upon thermogenic activation. During this process, brown adipocytes and immune cells, such as macrophages, contribute to thermogenesis and energy expenditure. Among the various functions exerted by macrophages, the clearance of dying cells, known as efferocytosis, is a key regulator of tissue remodeling across multiple organs in both physiological and pathological contexts. However, whether macrophages contribute to BAT remodeling and thermogenic adaptation through efferocytosis, and what drives efferocytosis in BAT, remain unknown. Here, we identify norepinephrine (NE), which is highly released in BAT upon cold challenge, as a tissue-specific trigger of macrophage efferocytosis. Transcriptomic and lipidomic analyses of BAT after cold exposure revealed a population of lipid-handling macrophages enriched in efferocytosis-related transcripts. Consistently, cold exposure enhanced the efferocytic capacity of BAT macrophages. These effects were recapitulated by stimulation of macrophages with NE and were dependent on {beta}2-adrenergic signaling and the efferocytic receptors AXL and MERTK. Mice lacking Axl and Mertk in macrophages exhibited impaired lipolysis, reduced thermogenic gene expression, and increased adipose tissue inflammation. Together, our findings identify a so far neglected role for NE in adipose tissue, linking sympathetic activation to macrophage efferocytosis and thereby promoting tissue remodeling and metabolic adaptation. Uncovering the role of NE in one of the core functions of macrophages, efferocytosis, not only expands our understanding of the multifaceted effects of NE on the immune system but also highlights therapeutic potential for targeting impaired efferocytosis in metabolic disorders. One sentence summaryNorepinephrine is a novel trigger of macrophage efferocytosis in brown adipose tissue, linking sympathetic signaling to metabolic adaptation and macrophage tissue remodeling responses through {beta}2-adrenergic and Axl/Mertk pathways.

immunology↗

bioRxiv2025

Dietary tryptophan enhances aryl hydrocarbon receptor activation and reduces colitis through microbial metabolism

Background & AimDisrupted microbial tryptophan metabolism and impaired aryl hydrocarbon receptor (AhR) activation are implicated in inflammatory bowel disease (IBD) pathogenesis. However, strategies to restore this pathway through diet or microbial modulation remain poorly defined. This study investigates how dietary tryptophan and human and mouse microbiota modulate metabolism, AhR activation, and intestinal inflammation in preclinical models. MethodsGnotobiotic mice colonized with microbiota of varying complexity or human fecal microbiota from ulcerative colitis (UC) patients and healthy controls were used to assess the impact of microbiota and dietary tryptophan supplementation on AhR activation and colitis severity. Chemically induced and spontaneous colitis models were investigated. ResultsIBD fecal samples showed reduced AhR activation compared to healthy controls, and fecal microbiota transplantation into germ-free mice demonstrated that impaired AhR is microbiota-dependent. Mice colonized with minimal microbiota had impaired microbial tryptophan metabolism, lower AhR activation, and worsened colitis severity compared to those colonized with complex microbiota. Dietary tryptophan supplementation in conventional and UC-humanized mice enhanced microbial production of AhR agonists, restored AhR activation, and reduced colitis severity in an AhR-dependent manner. Co-colonization with a tryptophan-metabolizing bacterium, Clostridium sporogenes, further improved tryptophan metabolism and colitis severity in mice with impaired microbial tryptophan metabolism. ConclusionsMicrobial tryptophan metabolism is critical for determining intestinal inflammation. Dietary tryptophan supplementation restores microbial metabolic pathways, mitigates colitis severity in preclinical models, and may address key metabolic deficiencies in IBD patients with impaired tryptophan metabolism. This study demonstrates the therapeutic potential of targeting microbial metabolism with diet in IBD management.

physiology↗

bioRxiv2025

MAIT cell responses to intracellular and extracellular pathogens are mediated by distinct antigen presenting cells

Mucosal-associated invariant T (MAIT) cells recognize microbial derivatives of riboflavin synthesis presented by the MHC class I-related (MR1) molecule. Although these metabolites are highly conserved among bacteria, the cells that present them remain unknown. Here, we show type-17 MAIT cells respond to diverse isolates of the extracellular pathogen Acinetobacter baumannii and promote bacterial clearance. Both hematopoietic and non-hematopoietic cells mediate MR1 presentation within the lungs and mediastinal lymph nodes (meLNs). Conversely, the type-1 MAIT cell response to the intracellular pathogen Francisella tularensis requires MR1 presentation by type-2 conventional dendritic cells (cDC2s) within meLNs and ablation of these cells or their expression of MR1 renders animals more susceptible to the infection. Although MR1 is broadly expressed at homeostasis, A. baumannii enhances MR1 on macrophages and fibroblasts, while F. tularensis increases expression on cDC2s. These results demonstrate that microbial tropism dictates which APCs mediate MR1 presentation of metabolites, revealing alternative therapeutic approaches.

immunology↗

bioRxiv2024

Antibiotic use in early life subsequently impairs MAIT cell-mediated immunity

Mucosal-associated invariant T (MAIT) cells are predominantly located in barrier tissues where they rapidly respond to pathogens and commensals by recognizing microbial derivatives of riboflavin synthesis. Early-life exposure to these metabolites imprints the abundance of MAIT cells within tissues, so we hypothesized that antibiotic use during this period may abrogate their development. We identified antibiotics that deplete riboflavin-synthesizing commensals and revealed an early period of susceptibility during which antibiotic administration impaired MAIT cell development. The reduction in MAIT cell abundance rendered mice more susceptible to pneumonia, while MAIT cell-deficient mice were unaffected by early-life antibiotics. Concomitant administration of a riboflavin-synthesizing commensal during antibiotic treatment was sufficient to restore MAIT cell development and immunity. Our work demonstrates that transient depletion of riboflavin-synthesizing commensals in early life can adversely affect responses to subsequent infections.

immunology↗

bioRxiv2024

SYNTERUPTOR: mining genomic islands for non-classical specialised metabolite gene clusters

Microbial specialised metabolite biosynthetic gene clusters (SMBGCs) are a formidable source of natural products of pharmaceutical interest. With the multiplication of genomic data available, very efficient bioinformatic tools for automatic SMBGC detection have been developed. Nevertheless, most of these tools identify SMBGCs based on sequence similarity with enzymes typically involved in specialised metabolism and thus may miss SMBGCs coding for under characterised enzymes. Here we present SYNTERUPTOR (https://bioi2.i2bc.paris-saclay.fr/synteruptor), a program that identifies genomic islands, known to be enriched in SMBGCs, in the genomes of closely related species. With this tool, we identified a SMBGC in the genome of Streptomyces ambofaciens ATCC23877, undetected by earlier versions of antiSMASH, and experimentally demonstrated that it directs the biosynthesis of two metabolites, one of which was identified as sphydrofuran. SYNTERUPTOR is also a valuable resource for the delineation of individual SMBGCs within antiSMASH regions that may encompass multiple clusters, and for refining the boundaries of these SMBGCs.

bioinformatics↗

bioRxiv2021

Metabolite Damage and Damage-Control in a Minimal Genome

Analysis of the genes retained in the minimized Mycoplasma JCVI-Syn3A genome established that systems that repair or preempt metabolite damage are essential to life. Several genes with known metabolite damage repair or preemption functions were identified and experimentally validated, including 5-formyltetrahydrofolate cyclo-ligase, CoA disulfide reductase, and certain hydrolases. Furthermore, we discovered that an enigmatic YqeK hydrolase domain fused to NadD has a novel proofreading function in NAD synthesis and could double as a MutT-like sanitizing enzyme for the nucleotide pool. Finally, we combined metabolomics and cheminformatics approaches to extend the core metabolic map of JCVI-Syn3A to include promiscuous enzymatic reactions and spontaneous side reactions. This extension revealed that several key metabolite damage-control systems remain to be identified in JCVI-Syn3A, such as that for methylglyoxal.

microbiology↗